|
Exclusive conversations with our portfolio managers, who share their unique perspective on various topics, which includes investment strategies and Fund updates.
| VenGrowth Advanced Life Sciences Fund Update |
(Recorded - Jan. 2008)
|
|
|
|
Dr. Luc Marengère, Managing General Partner reflects on 2007 performance, and provides a general update including:
-
Foreign exchange impact on the Fund
-
Robust partnership and IPO activity continues in life sciences sector
-
Recent developments for investee companies Aegera Therapeutics, Z-Tech and Zelos Therapeutics
|
Play video
|
|
| VenGrowth Traditional Industries Fund Update |
(Recorded - Jan. 2008)
|
|
|
|
Graham McBride, VenGrowth Managing General Partner gives an update on the portfolio’s performance, and gives his insight as to why the Fund is one of the most stable and conservative LSIFs in the industry:
-
Impact of cash position on the Fund’s performance
-
How the credit crunch has created investment opportunities
for the Fund
-
How the Fund is well-positioned to weather an economic downturn
-
Recent investee company developments on Great Lakes Fish Corp and MPI Packaging Inc.
|
Play video
|
|
| VenGrowth Advanced Life Sciences Fund Update
|
(Recorded - Oct. 2007)
|
|
|
|
VenGrowth Managing General Partner, Dr. Luc Marengère, gives a quarterly update highlighting maturity of investee companies and other topics including:
-
How life sciences, like venture capital, is cyclical in nature
-
Mounting evidence that biotech is poised to rebound
-
Effect of strong C$ on the Fund
|
Play video
|
|
| VenGrowth Traditional Industries Fund Update |
(Recorded - Sept. 2007)
|
|
|
|
VenGrowth Managing General Partner, Graham McBride offers an insightful quarterly update highlighting:
|
Play video
|
|
|
